(function(){var loadHandler=window['sl_{315D1622-408A-44AB-A0C3-DE05A398C304}'];loadHandler&&loadHandler(29, '<div id="spr0_448a53"><div id="spr1_448a53" class="kern"><img id="img0_448a53" src="data/img0.png" width="720px" height="540px" alt="" style="left:0px;top:0px;"/></div><div id="spr2_448a53" class="kern"><div id="spr3_448a53" style="left:225.15px;top:10.8px;"><div style="width:0px;"><span id="txt0_448a53" class="relpos" style="left:7.137px;top:5.73px;">conclusion</span></div></div><div id="spr4_448a53" style="left:33.975px;top:98.85px;"><div style="width:0px;"><span id="txt1_448a53" class="relpos" style="left:7.2px;top:12.353px;">1.</span><span id="txt2_448a53" class="relpos" style="left:7.195px;top:12.353px;">pNENs</span><span id="txt3_448a53" class="relpos" style="left:7.19px;top:12.353px;"> can be successfully treated by EUS-EI.The therapy could improve</span></div><div style="width:0px;"><span id="txt4_448a53" class="relpos" style="left:55.2px;top:48.353px;">hypoglycemic sympotoms by increasing FBG and decreasing serum</span></div><div style="width:0px;"><span id="txt5_448a53" class="relpos" style="left:55.2px;top:84.353px;">insulin  and C-peptide.</span></div><div style="width:0px;"><span id="txt6_448a53" class="relpos" style="left:7.2px;top:125.153px;">2.Treatment and follow-up scheme should be decided according to the tumor</span></div><div style="width:0px;"><span id="txt7_448a53" class="relpos" style="left:55.2px;top:161.153px;">size in order to improve personalized treatment.</span></div><div style="width:0px;"><span id="txt8_448a53" class="relpos" style="left:7.2px;top:201.953px;">3.CE-EUS is a useful tool in  </span><span id="txt9_448a53" class="relpos" style="left:7.195px;top:201.953px;">diagnosis ,treatment and follow up to pNETs.</span></div></div></div></div>');})();